Impact of Antichlamydial Treatment on the Rate of Preeclampsia
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
This randomized, double blinded controlled trial included 1200 healthy primigravidae who
attended an outpatient clinic at 16-20weeks of pregnancy. All women were randomly divided
equally into two groups, group A(600 women) who received antichlamydial treatment in the form
of azithromycin 1 gram single oral dose before 20 weeks of pregnancy and group B (600 women)
who received no treatment(placebo). All participants were followed up for up to 6 weeks
postpartum and observed for the development of preeclampsia.